← Open Payments lookup

JODY FOWERS: Open Payments

NPI 1992915052 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$755 in 35 payments from 20 companies in 2025. Trend: 2023 $918 · 2024 $972 · 2025 $755

Food & beverage: $655Education: $100
CompanyPaymentsAmount
Astellas Pharma US Inc2$117
ABBVIE INC.5$107
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$97
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$46
Organon LLC3$41
Neurocrine BioSciences, Inc.2$38
GlaxoSmithKline, LLC.2$33
Phathom Pharmaceuticals, Inc.3$31
Neuronetics, Inc.1$28
Vanda Pharmaceuticals Inc.1$27

Products named: CAPLYTA, VRAYLAR, XIFAXAN, NEXPLANON, INGREZZA, VOQUEZNA, NEUROSTAR TMS THERAPY SYSTEM, UBRELVY.

Industry payments across UT — which companies pay providers there.